William Plovanic
Stock Analyst at Canaccord Genuity
(3.15)
# 1,517
Out of 4,496 analysts
86
Total ratings
44.58%
Success rate
1.79%
Average return
Main Sectors:
21 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANGO AngioDynamics | Maintains: Buy | $18 → $13 | $7.18 | +81.06% | 4 | Jul 17, 2024 | |
| TLSI TriSalus Life Sciences | Maintains: Buy | $12 | $5.55 | +116.22% | 2 | Jun 27, 2024 | |
| NVRO Nevro | Maintains: Hold | $17 → $11 | $9.10 | +20.88% | 9 | May 8, 2024 | |
| BVS Bioventus | Maintains: Buy | $7 → $8 | $7.17 | +11.58% | 2 | May 8, 2024 | |
| IRTC iRhythm Technologies | Maintains: Buy | $133 → $122 | $98.97 | +23.27% | 7 | May 3, 2024 | |
| ATRC AtriCure | Maintains: Buy | $57 → $49 | $24.17 | +102.73% | 7 | May 2, 2024 | |
| NARI Inari Medical | Maintains: Buy | $75 → $55 | $54.90 | +0.18% | 9 | May 1, 2024 | |
| CVRX CVRx, Inc. | Maintains: Buy | $32 → $14 | $9.36 | +49.57% | 3 | May 1, 2024 | |
| EW Edwards Lifesciences | Maintains: Hold | $86 → $85 | $86.50 | -1.73% | 6 | Apr 26, 2024 | |
| DXCM DexCom | Maintains: Buy | $144 → $145 | $111.66 | +29.86% | 1 | Apr 26, 2024 | |
| PEN Penumbra | Reiterates: Buy | $284 | $189.87 | +49.58% | 4 | Feb 23, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $22 → $25 | $11.09 | +125.43% | 1 | Jan 22, 2024 | |
| BSX Boston Scientific | Maintains: Buy | $60 → $64 | $77.56 | -17.48% | 5 | Nov 27, 2023 | |
| LUNG Pulmonx | Maintains: Buy | $20 → $12 | $7.92 | +51.52% | 4 | Oct 31, 2023 | |
| MMSI Merit Medical Systems | Maintains: Hold | $86 → $70 | $85.49 | -18.12% | 4 | Aug 28, 2023 | |
| STAA STAAR Surgical Company | Downgrades: Hold | $77 → $48 | $42.50 | +12.94% | 5 | Aug 3, 2023 | |
| YMAB Y-mAbs Therapeutics | Maintains: Buy | $21 → $22 | $11.59 | +89.82% | 3 | Jul 25, 2023 | |
| TMDX TransMedics Group | Maintains: Buy | $91 → $86 | $147.20 | -41.58% | 3 | May 18, 2023 | |
| STIM Neuronetics | Maintains: Buy | $9 → $7 | $1.93 | +263.64% | 1 | Mar 8, 2023 | |
| VAPO Vapotherm | Downgrades: Hold | $96 → $40 | $2.15 | +1,760.47% | 2 | May 6, 2022 | |
| AFIB Acutus Medical | Downgrades: Hold | $10 → $3 | $0.03 | +9,577.42% | 4 | Jan 14, 2022 |
AngioDynamics
Jul 17, 2024
Maintains: Buy
Price Target: $18 → $13
Current: $7.18
Upside: +81.06%
TriSalus Life Sciences
Jun 27, 2024
Maintains: Buy
Price Target: $12
Current: $5.55
Upside: +116.22%
Nevro
May 8, 2024
Maintains: Hold
Price Target: $17 → $11
Current: $9.10
Upside: +20.88%
Bioventus
May 8, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $7.17
Upside: +11.58%
iRhythm Technologies
May 3, 2024
Maintains: Buy
Price Target: $133 → $122
Current: $98.97
Upside: +23.27%
AtriCure
May 2, 2024
Maintains: Buy
Price Target: $57 → $49
Current: $24.17
Upside: +102.73%
Inari Medical
May 1, 2024
Maintains: Buy
Price Target: $75 → $55
Current: $54.90
Upside: +0.18%
CVRx, Inc.
May 1, 2024
Maintains: Buy
Price Target: $32 → $14
Current: $9.36
Upside: +49.57%
Edwards Lifesciences
Apr 26, 2024
Maintains: Hold
Price Target: $86 → $85
Current: $86.50
Upside: -1.73%
DexCom
Apr 26, 2024
Maintains: Buy
Price Target: $144 → $145
Current: $111.66
Upside: +29.86%
Penumbra
Feb 23, 2024
Reiterates: Buy
Price Target: $284
Current: $189.87
Upside: +49.58%
Alphatec Holdings
Jan 22, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $11.09
Upside: +125.43%
Boston Scientific
Nov 27, 2023
Maintains: Buy
Price Target: $60 → $64
Current: $77.56
Upside: -17.48%
Pulmonx
Oct 31, 2023
Maintains: Buy
Price Target: $20 → $12
Current: $7.92
Upside: +51.52%
Merit Medical Systems
Aug 28, 2023
Maintains: Hold
Price Target: $86 → $70
Current: $85.49
Upside: -18.12%
STAAR Surgical Company
Aug 3, 2023
Downgrades: Hold
Price Target: $77 → $48
Current: $42.50
Upside: +12.94%
Y-mAbs Therapeutics
Jul 25, 2023
Maintains: Buy
Price Target: $21 → $22
Current: $11.59
Upside: +89.82%
TransMedics Group
May 18, 2023
Maintains: Buy
Price Target: $91 → $86
Current: $147.20
Upside: -41.58%
Neuronetics
Mar 8, 2023
Maintains: Buy
Price Target: $9 → $7
Current: $1.93
Upside: +263.64%
Vapotherm
May 6, 2022
Downgrades: Hold
Price Target: $96 → $40
Current: $2.15
Upside: +1,760.47%
Acutus Medical
Jan 14, 2022
Downgrades: Hold
Price Target: $10 → $3
Current: $0.03
Upside: +9,577.42%